Mutita Junking Selected Research

2- (4- acetoxyphenyl)- 2- chloro- N- methylethylamine

1/2020	Anti-Proliferative Effects of Compound A and Its Effect in Combination with Cisplatin in Cholangiocarcinoma Cells.
12/2015	Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mutita Junking Research Topics

Disease

12	Neoplasms (Cancer) 04/2022 - 03/2008
11	Cholangiocarcinoma 01/2022 - 03/2008
5	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2017 - 10/2010
4	Infections 01/2019 - 11/2015
2	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2021
2	Carcinoma (Carcinomatosis) 04/2018 - 12/2015
2	Cytokine Release Syndrome 12/2015 - 06/2012
2	Kidney Diseases (Kidney Disease) 07/2014 - 10/2010
1	Multiple Myeloma 04/2022
1	Bites and Stings (Sting) 01/2022
1	Hyperglycemia 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 11/2019
1	Kidney Calculi (Kidney Stone) 07/2018
1	Insulinoma 03/2015
1	Neoplasm Metastasis (Metastasis) 03/2008

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2008
7	AntigensIBA 04/2022 - 10/2017
5	dirhodium tetraacetate (DRTA)IBA 01/2017 - 10/2010
4	Chimeric Antigen ReceptorsIBA 02/2021 - 12/2020
4	CytokinesIBA 10/2020 - 06/2012
2	Folate Receptor 1IBA 01/2022 - 02/2021
2	Gemcitabine FDA Link 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 10/2020 - 01/2018
2	2- (4- acetoxyphenyl)- 2- chloro- N- methylethylamineIBA 01/2020 - 12/2015
2	Neoplasm Antigens (Tumor Antigens)IBA 11/2019 - 10/2017
2	3' Untranslated Regions (3' UTR)IBA 01/2019 - 04/2018
2	Antiviral Agents (Antivirals)IBA 01/2019 - 12/2015
2	RNA (Ribonucleic Acid)IBA 01/2019 - 10/2017
2	MorpholinosIBA 01/2019 - 04/2018
2	Messenger RNA (mRNA)IBA 10/2017 - 03/2015
2	Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA 01/2017 - 09/2011
2	Protons (Proton)IBA 09/2011 - 10/2010
2	Galectin 3 (LGALS3)IBA 11/2009 - 03/2008
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 04/2022
1	B-Cell Maturation AntigenIBA 04/2022
1	atezolizumabIBA 01/2022
1	IntegrinsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	SteroidsIBA 01/2021
1	Antigen Receptors (Antigen Receptor)IBA 01/2021
1	Single-Chain AntibodiesIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2020
1	Interleukin-10 ReceptorsIBA 10/2020
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 10/2018
1	Voltage-Gated Sodium ChannelsIBA 07/2018
1	LigandsIBA 01/2018
1	Coat Protein Complex I (COPI)IBA 01/2017
1	ChloridesIBA 01/2017
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2017
1	AnionsIBA 01/2017
1	ChemokinesIBA 12/2015
1	Ribavirin (Virazole)FDA LinkGeneric 12/2015
1	VaccinesIBA 11/2015
1	Peptides (Polypeptides)IBA 11/2015
1	Glucose (Dextrose)FDA LinkGeneric 03/2015
1	Caspase 3 (Caspase-3)IBA 03/2015
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 03/2015
1	Testosterone (Sustanon)FDA Link 03/2015
1	Losartan (Cozaar)FDA LinkGeneric 03/2015
1	Angiotensin IIIBA 03/2015
1	Type 1 Angiotensin ReceptorIBA 03/2015
1	Galectins (Galectin)IBA 03/2008
1	Biological ProductsIBA 03/2008
1	Small Interfering RNA (siRNA)IBA 03/2008

Therapy/Procedure

6	Therapeutics 04/2022 - 03/2008
4	Immunotherapy 01/2021 - 10/2017
1	Drug Therapy (Chemotherapy) 01/2020